Presentation Download: Analytical Strategies To Accelerate Generic OINDP Development

In-vitro bioequivalence for the development of generic inhaled pharmaceutical products continues to present industry with significant and evolving challenges. This presentation by Mark Parry, Technical Director, covers the key regulatory aspects and analytical strategies to underpin the development of stronger in-vivo data packages supporting both greater clinical success and the possibility of successful in-vitro only generic approvals.

Download a copy of the presentation now by completing the form.